Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Propionic Acidemia Global Market Report 2025
Download Free Sample Buy Now
Global Propionic Acidemia Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Propionic Acidemia Global Market Report 2025

By Drug Class (L-Carnitine, Antibiotics), By Route of Administration ( Oral, Intravenous, Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Propionic Acidemia Market Overview

• Propionic Acidemia market size has reached to $2 billion in 2024

• Expected to grow to $2.43 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%

• Growth Driver: The Increase in Prevalence of Genetic Disorders Fueling the Growth of the Market Due to Rising Demand for Targeted Treatments and Early Detection

• Market Trend: Innovative mRNA-Based Therapies Advancing Treatment For Rare Genetic Disorders

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Propionic Acidemia Market?

Propionic Acidemia (PA) is a rare, inherited metabolic disorder caused by a deficiency in the enzyme propionyl-CoA carboxylase, which is essential for breaking down certain amino acids and fatty acids. This deficiency leads to the accumulation of toxic compounds in the blood, causing severe symptoms such as metabolic crises, neurological damage, and, if left untreated, can be life-threatening, especially in infancy.

The main drug classes of propionic acidemia are l-carnitine, antibiotics. L-Carnitine refers to a naturally occurring compound that plays a key role in the transport of long-chain fatty acids into mitochondria, where they are oxidized to produce energy. The various route of administration includes oral, intravenous, intramuscular. These are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies.

Propionic Acidemia Market Size and growth rate 2025 to 2029: Graph

What Is The Propionic Acidemia Market Size 2025 And Growth Rate?

The propionic acidemia market size has grown steadily in recent years. It will grow from $2.0 billion in 2024 to $2.07 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to the rise in disease prevalence, increase in newborn screening, rise in healthcare expenditure, increase in pediatric diagnoses, and growth in rare disease initiatives.

What Is The Propionic Acidemia Market Growth Forecast?

The propionic acidemia market size is expected to see steady growth in the next few years. It will grow to $2.43 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to increasing awareness campaigns, rising metabolic disorder cases, growing telemedicine adoption, increasing personalized treatment demand, and increasing healthcare investments. Major trends in the forecast period include technological advancements in diagnostics, development of gene therapies, advancements in metabolic therapies, integration of AI in healthcare, and development of novel therapeutics.

The forecast of 4.1% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. may experience higher treatment costs as metabolic diagnostic tools, enzyme assay kits, and specialty amino acid supplements sourced from the Netherlands and Germany become more expensive to support rare disease care. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Services Industry?

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are significantly impacting the services sector, particularly in business services, IT, and professional consulting operations. Higher costs for imported technology, office equipment, and essential digital infrastructure have raised operating expenses for service providers, forcing them to either pass on costs to clients or absorb margin pressures. Outsourcing firms and IT service companies are also facing challenges due to increased costs of hardware components and delayed global supply chains, affecting project delivery timelines and profitability. Additionally, retaliatory tariffs have dampened demand for U.S.-based professional services in key international markets, leading to a slowdown in export-driven revenue streams. The sector must now prioritize digital transformation, cost optimization, and expanding domestic client bases to sustain growth and maintain competitiveness amid ongoing trade uncertainty.

How Is The Propionic Acidemia Market Segmented?

1) By Drug Class: L-Carnitine, Antibiotics

2) By Route of Administration: Oral, Intravenous, Intramuscular

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegmentss:

1) By L-Carnitine Drug Class: Oral L-Carnitine, Injectable L-Carnitine

2) By Antibiotics Drug Class: Oral Antibiotics, Injectable Antibiotics

What Is Driving The Propionic Acidemia Market? The Increase in Prevalence of Genetic Disorders Fueling the Growth of the Market Due to Rising Demand for Targeted Treatments and Early Detection

The increasing prevalence of genetic disorders is expected to propel the growth of the propionic acidemia market going forward. Genetic disorders refer to the conditions caused by mutations or abnormalities in an individual's DNA, which can be inherited or occur spontaneously, affecting health and development. The increasing prevalence of genetic disorders is due to consanguineous marriages, as they increase the risk of inheriting recessive genetic mutations by allowing the same defective genes to be passed down from both parents, which significantly raises the likelihood of genetic conditions. Propionic acidemia enhances genetic disorder management by offering targeted treatments that address metabolic imbalances, improving patient outcomes. For instance, in July 2022, according to the report published by the Cystic Fibrosis (CF) Foundation, a US-based non-profit organization, the prevalence of cystic fibrosis has risen, affecting nearly 40,000 children and adults in the United States in 2022, with over 105,000 diagnosed globally. Therefore, the increasing prevalence of genetic disorders is driving the growth of the acidemia market.

Who Are The Major Players In The Global Propionic Acidemia Market?

Major companies operating in the propionic acidemia market are Moderna Therapeutics, Synlogic Therapeutics, Invitae Corporation, Global Calcium, BridgeBio Pharma, AdvaCare Pharma, HemoShear Therapeutics, DNA Labs, Velnex Medicare, Phytologix Life Scieneces, Liaoning Koncepnutra Co. Ltd., Propionic Acidemia Foundation, Agex Pharma, Gladfem, CSL Behring, Octapharma AG, Sanquin, Kedrion SpA, Shire plc, Vitane Pharmaceuticals Inc.

What Are The Key Trends Of The Global Propionic Acidemia Market? Innovative mRNA-Based Therapies Advancing Treatment For Rare Genetic Disorders

Major companies operating in the propionic acidemia market are focusing on developing innovative mRNA-based treatments to address the underlying genetic causes of the disease. mRNA therapies are a type of treatment that use messenger RNA to instruct cells to produce proteins that can prevent or treat diseases by targeting the underlying causes at a genetic level. For instance, in May 2023, Moderna, a US-based pharmaceutical and biotechnology company, presented interim data from the Phase 1/2 trial of mRNA-3927, an investigational mRNA therapy for propionic acidemia. The therapy uses mRNA to deliver functional copies of the PCCA and PCCB genes, restoring enzyme activity in the liver and potentially reducing metabolic decompensations, with this innovative treatment approach aiming to improve patient outcomes by addressing the genetic root cause of the disease, offering new hope for individuals affected by this rare metabolic disorder.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Propionic Acidemia Market? Ironwood Pharma Acquires Vectivbio To Advance Propionic Acidemia Treatments

In May 2023, Ironwood Pharmaceuticals Inc., a US-based biotechnology company, acquired VectivBio for approximately $1 billion USD. With this acquisition, Ironwood aims to strengthen its rare disease pipeline by leveraging VectivBio’s novel therapies, including investigational treatments for propionic acidemia. VectivBio is a Switzerland-based biotechnology company specialized in developing treatments for rare gastrointestinal and metabolic disorders.

What Is The Regional Outlook For The Global Propionic Acidemia Market?

North America was the largest region in the propionic acidemia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Propionic Acidemia Market?

The propionic acidemia market includes revenues earned by entities through enzyme replacement therapy (ERT), nutritional therapy services, personalized care management services, patient support programs, and pharmacogenomic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Propionic Acidemia Industry?

The propionic acidemia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the propionic acidemia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Propionic Acidemia Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.07 billion
Revenue Forecast In 2034 $2.43 billion
Growth Rate CAGR of 4.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The propionic acidemia market covered in this report is segmented –
1) By Drug Class: L-Carnitine, Antibiotics
2) By Route of Administration: Oral, Intravenous, Intramuscular
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegmentss:
1) By L-Carnitine Drug Class: Oral L-Carnitine, Injectable L-Carnitine
2) By Antibiotics Drug Class: Oral Antibiotics, Injectable Antibiotics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Moderna Therapeutics, Synlogic Therapeutics, Invitae Corporation, Global Calcium, BridgeBio Pharma, AdvaCare Pharma, HemoShear Therapeutics, DNA Labs, Velnex Medicare, Phytologix Life Scieneces, Liaoning Koncepnutra Co. Ltd., Propionic Acidemia Foundation, Agex Pharma, Gladfem, CSL Behring, Octapharma AG, Sanquin, Kedrion SpA, Shire plc, Vitane Pharmaceuticals Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Propionic Acidemia Market Characteristics

3. Propionic Acidemia Market Trends And Strategies

4. Propionic Acidemia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Propionic Acidemia Growth Analysis And Strategic Analysis Framework

5.1. Global Propionic Acidemia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Propionic Acidemia Market Growth Rate Analysis

5.4. Global Propionic Acidemia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Propionic Acidemia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Propionic Acidemia Total Addressable Market (TAM)

6. Propionic Acidemia Market Segmentation

6.1. Global Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

L-Carnitine

Antibiotics

6.2. Global Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Intramuscular

6.3. Global Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.4. Global Propionic Acidemia Market, Sub-Segmentation Of L-Carnitine, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectable

6.5. Global Propionic Acidemia Market, Sub-Segmentation Of Antibiotics, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectable

7. Propionic Acidemia Market Regional And Country Analysis

7.1. Global Propionic Acidemia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Propionic Acidemia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Propionic Acidemia Market

8.1. Asia-Pacific Propionic Acidemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Propionic Acidemia Market

9.1. China Propionic Acidemia Market Overview

9.2. China Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Propionic Acidemia Market

10.1. India Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Propionic Acidemia Market

11.1. Japan Propionic Acidemia Market Overview

11.2. Japan Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Propionic Acidemia Market

12.1. Australia Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Propionic Acidemia Market

13.1. Indonesia Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Propionic Acidemia Market

14.1. South Korea Propionic Acidemia Market Overview

14.2. South Korea Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Propionic Acidemia Market

15.1. Western Europe Propionic Acidemia Market Overview

15.2. Western Europe Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Propionic Acidemia Market

16.1. UK Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Propionic Acidemia Market

17.1. Germany Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Propionic Acidemia Market

18.1. France Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Propionic Acidemia Market

19.1. Italy Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Propionic Acidemia Market

20.1. Spain Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Propionic Acidemia Market

21.1. Eastern Europe Propionic Acidemia Market Overview

21.2. Eastern Europe Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Propionic Acidemia Market

22.1. Russia Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Propionic Acidemia Market

23.1. North America Propionic Acidemia Market Overview

23.2. North America Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Propionic Acidemia Market

24.1. USA Propionic Acidemia Market Overview

24.2. USA Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Propionic Acidemia Market

25.1. Canada Propionic Acidemia Market Overview

25.2. Canada Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Propionic Acidemia Market

26.1. South America Propionic Acidemia Market Overview

26.2. South America Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Propionic Acidemia Market

27.1. Brazil Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Propionic Acidemia Market

28.1. Middle East Propionic Acidemia Market Overview

28.2. Middle East Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Propionic Acidemia Market

29.1. Africa Propionic Acidemia Market Overview

29.2. Africa Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Propionic Acidemia Market Competitive Landscape And Company Profiles

30.1. Propionic Acidemia Market Competitive Landscape

30.2. Propionic Acidemia Market Company Profiles

30.2.1. Moderna Therapeutics Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Synlogic Therapeutics Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Global Calcium Overview, Products and Services, Strategy and Financial Analysis

30.2.5. BridgeBio Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Propionic Acidemia Market Other Major And Innovative Companies

31.1. AdvaCare Pharma

31.2. HemoShear Therapeutics

31.3. DNA Labs

31.4. Velnex Medicare

31.5. Phytologix Life Scieneces

31.6. Liaoning Koncepnutra Co. Ltd.

31.7. Propionic Acidemia Foundation

31.8. Agex Pharma

31.9. Gladfem

31.10. CSL Behring

31.11. Octapharma AG

31.12. Sanquin

31.13. Kedrion SpA

31.14. Shire plc

31.15. Vitane Pharmaceuticals Inc.

32. Global Propionic Acidemia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Propionic Acidemia Market

34. Recent Developments In The Propionic Acidemia Market

35. Propionic Acidemia Market High Potential Countries, Segments and Strategies

35.1 Propionic Acidemia Market In 2029 - Countries Offering Most New Opportunities

35.2 Propionic Acidemia Market In 2029 - Segments Offering Most New Opportunities

35.3 Propionic Acidemia Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Propionic Acidemia Market, Sub-Segmentation Of L-Carnitine, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Propionic Acidemia Market, Sub-Segmentation Of Antibiotics, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Propionic Acidemia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Propionic Acidemia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Moderna Therapeutics Financial Performance
  • Table 77: Synlogic Therapeutics Financial Performance
  • Table 78: Invitae Corporation Financial Performance
  • Table 79: Global Calcium Financial Performance
  • Table 80: BridgeBio Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Propionic Acidemia Market, Sub-Segmentation Of L-Carnitine, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Propionic Acidemia Market, Sub-Segmentation Of Antibiotics, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Propionic Acidemia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Propionic Acidemia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Moderna Therapeutics Financial Performance
  • Figure 77: Synlogic Therapeutics Financial Performance
  • Figure 78: Invitae Corporation Financial Performance
  • Figure 79: Global Calcium Financial Performance
  • Figure 80: BridgeBio Pharma Financial Performance

Explore emerging trends, market share, and growth drivers in the global Takaful Market through 2034.

Read More About Explore emerging trends, market share, and growth drivers in the global Takaful Market through 2034.

Explore insights and forecasts of the NGOs and charitable organizations market through 2034 for strategic decision-making.

Read More About Explore insights and forecasts of the NGOs and charitable organizations market through 2034 for strategic decision-making.

Unlocking Opportunities in the Surface Protection Service Market: Key Trends, Market Growth, and Forecast Insights

Read More About Unlocking Opportunities in the Surface Protection Service Market: Key Trends, Market Growth, and Forecast Insights

Synthetic Sapphire Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034

Read More About Synthetic Sapphire Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034

Traditional Travel Agency Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Read More About Traditional Travel Agency Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

How the Travel Agency Services Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025

Read More About How the Travel Agency Services Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025

Citric Acid Market 2024 – By Type (Packed Bed Filters, Combination Filters), By Filter (Granular Activated Carbon, Potassium Permanganate, Impregnated Activated Carbon), By End User (Pulp And Paper Industry, Chemicals An...

Propionic Acid Global Market Report 2025 – By Product (Oxo Process, Reppe Process, By-product Process), By Application (Herbicides, Rubber Products, Plasticizers, Food Preservatives, Other Applications), By End-User Indu...

Hydrochloric Acid Global Market Report 2025 – By Type( Synthetic Hydrochloric Acid, By-Product Hydrochloric Acid), By Form( Water-Based, Aqueous, Solution), By Distribution Channel( E-Commerce, B2B, Specialty Stores, Oth...

Phosphoric Acid Global Market Report 2025 – By Type (Calcium Phosphate, Sodium Tripolyphosphate, Potassium Phosphate, Other Types), By Grade (Food, Agricultural, Industrial), By Process Type (Furnace Process, Dry Kiln Pr...

Acidity Regulators Global Market Report 2025 – By Product (Citric Acid, Phosphoric Acid, Acetic Acid, Maleic Acid, Lactic Acid, Other Products), By Source (Natural, Synthetic), By Application (Beverages, Bakery Products,...

Ursolic Acid Global Market Report 2025 – By Type (25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, 98% Ursolic Acid, Other Types), By Form (Powdered Form, Capsules, Liquid Form), By End-Use (Pharmaceuticals, Food an...

Glucaric Acid Global Market Report 2025 – By Type (Calcium D-Glucarate, Pure Glucaric Acid, D-Glucaric Acid-1,4-Lactone, Potassium Sodium D-Glucarate, Other Types), By Application (Detergents, Healthcare, Food Manufactur...

Food Acidulants Global Market Report 2025 – By Type (Citric Acid, Lactic Acid, Acetic Acid, Phosphoric Acid, Malic Acid, Other Types), By Form (Solid, Liquid), By Application (Beverages, Dairy And Frozen products, Bakery...

Frequently Asked Questions

Propionic Acidemia (PA) is a rare, inherited metabolic disorder caused by a deficiency in the enzyme propionyl-CoA carboxylase, which is essential for breaking down certain amino acids and fatty acids. This deficiency leads to the accumulation of toxic compounds in the blood, causing severe symptoms such as metabolic crises, neurological damage, and, if left untreated, can be life-threatening, especially in infancy. For further insights on this market, request a sample here

The market major growth driver - The Increase in Prevalence of Genetic Disorders Fueling the Growth of the Market Due to Rising Demand for Targeted Treatments and Early Detection. For further insights on this market, request a sample here

The propionic acidemia market size has grown steadily in recent years. It will grow from $2 billion in 2024 to $2.07 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to the rise in disease prevalence, increase in newborn screening, rise in healthcare expenditure, increase in pediatric diagnoses, and growth in rare disease initiatives. The propionic acidemia market size is expected to see steady growth in the next few years. It will grow to $2.43 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to increasing awareness campaigns, rising metabolic disorder cases, growing telemedicine adoption, increasing personalized treatment demand, and increasing healthcare investments. Major trends in the forecast period include technological advancements in diagnostics, development of gene therapies, advancements in metabolic therapies, integration of AI in healthcare, and development of novel therapeutics. For further insights on this market, request a sample here

The propionic acidemiamarket covered in this report is segmented –
1) By Drug Class: L-Carnitine, Antibiotics
2) By Route of Administration: Oral, Intravenous, Intramuscular
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments:
1) By L-Carnitine Drug Class: Oral L-Carnitine, Injectable L-Carnitine
2) By Antibiotics Drug Class: Oral Antibiotics, Injectable Antibiotics For further insights on this market, request a sample here

North America was the largest region in the propionic acidemia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the propionic acidemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the propionic acidemia market are Moderna Therapeutics, Synlogic Therapeutics, Invitae Corporation, Global Calcium, BridgeBio Pharma, AdvaCare Pharma, HemoShear Therapeutics, DNA Labs, Velnex Medicare, Phytologix Life Scieneces, Liaoning Koncepnutra Co. Ltd., Propionic Acidemia Foundation, Agex Pharma, Gladfem, CSL Behring, Octapharma AG, Sanquin, Kedrion SpA, Shire plc, Vitane Pharmaceuticals Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative mRNA-Based Therapies Advancing Treatment For Rare Genetic Disorders. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Propionic Acidemia Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon